Arrowhead Pharmaceuticals, Inc.Arrowhead Pharmaceuticals, Inc.Arrowhead Pharmaceuticals, Inc.

Arrowhead Pharmaceuticals, Inc.

No trades
See on Supercharts

Price target

53.660.00 0.00%
The 14 analysts offering 1 year price forecasts for ARWR have a max estimate of — and a min estimate of —.

Analyst rating

Based on 15 analysts giving stock ratings to ARWR in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions

ARWR EPS for the last quarter is −1.24 USD despite the estimation of −0.80 USD. In the next quarter EPS is expected to reach −0.47 USD. Track more of Arrowhead Pharmaceuticals, Inc. financials and stay on top of what is up with the company.
In the next quarter Arrowhead Pharmaceuticals, Inc. revenue is expected to reach ‪41.97 M‬ USD. Check out Arrowhead Pharmaceuticals, Inc. revenue and earnings and make informed decisions.
According to analysts, ARWR price target is 53.66 USD with a max estimate of 90.00 USD and a min estimate of 28.00 USD. Check if this forecast comes true in a year, meanwhile keep track of the current situation with ARWR news and stock market news.
We've gathered opinions of 15 analysts rating ARWR stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as buy. Note that it's not a trading advice — your own analysis is still required.